Clinical trial
Development Of Adipose-Derived Mesenchymal Stem Cells Secretome (ADMSCS) Based Products From Stem Cell Conditioned Medium For Melasma Therapy
NCT07137130 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development Of Adipose-Derived Mesenchymal Stem Cells Secretome (ADMSCS) Based Products From Stem Cell Conditioned Medium For Melasma Therapy
- Lead sponsor
- Indonesia University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 14, 2026
- Completion date
- December 20, 2026
- Enrollment
- 34 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melasma